211 related articles for article (PubMed ID: 28642035)
1. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
2. 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells.
Segala G; de Medina P; Iuliano L; Zerbinati C; Paillasse MR; Noguer E; Dalenc F; Payré B; Jordan VC; Record M; Silvente-Poirot S; Poirot M
Biochem Pharmacol; 2013 Jul; 86(1):175-89. PubMed ID: 23500540
[TBL] [Abstract][Full Text] [Related]
3. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
Silvente-Poirot S; de Medina P; Record M; Poirot M
Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
[TBL] [Abstract][Full Text] [Related]
4. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
Cook KL; Wärri A; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Clarke R
Clin Cancer Res; 2014 Jun; 20(12):3222-32. PubMed ID: 24928945
[TBL] [Abstract][Full Text] [Related]
6. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
[TBL] [Abstract][Full Text] [Related]
7. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.
de Medina P; Paillasse MR; Ségala G; Khallouki F; Brillouet S; Dalenc F; Courbon F; Record M; Poirot M; Silvente-Poirot S
Chem Phys Lipids; 2011 Sep; 164(6):432-7. PubMed ID: 21641337
[TBL] [Abstract][Full Text] [Related]
8. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism.
de Medina P; Payré B; Boubekeur N; Bertrand-Michel J; Tercé F; Silvente-Poirot S; Poirot M
Cell Death Differ; 2009 Oct; 16(10):1372-84. PubMed ID: 19521424
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
10. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
Osipo C; Gajdos C; Cheng D; Jordan VC
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):249-56. PubMed ID: 15860267
[TBL] [Abstract][Full Text] [Related]
11. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands.
de Medina P; Paillasse MR; Segala G; Poirot M; Silvente-Poirot S
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13520-5. PubMed ID: 20615952
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen and AEBS ligands induced apoptosis and autophagy in breast cancer cells through the stimulation of sterol accumulation.
de Medina P; Silvente-Poirot S; Poirot M
Autophagy; 2009 Oct; 5(7):1066-7. PubMed ID: 19738414
[TBL] [Abstract][Full Text] [Related]
13. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism.
Shim JS; Li RJ; Lv J; Head SA; Yang EJ; Liu JO
Cancer Lett; 2015 Jun; 362(1):106-15. PubMed ID: 25799952
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen mediated estrogen receptor activation protects against early impairment of hippocampal neuron excitability in an oxygen/glucose deprivation brain slice ischemia model.
Zhang H; Xie M; Schools GP; Feustel PF; Wang W; Lei T; Kimelberg HK; Zhou M
Brain Res; 2009 Jan; 1247():196-211. PubMed ID: 18992727
[TBL] [Abstract][Full Text] [Related]
16. Estrogen can restore Tamoxifen sensitivity in breast cancer cells amidst the complex network of resistance.
Mansouri S; Farahmand L; Hosseinzade A; Eslami-S Z; Majidzadeh-A K
Biomed Pharmacother; 2017 Sep; 93():1320-1325. PubMed ID: 28747013
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of acquired antiestrogen resistance and its management in breast cancer].
Iino Y; Maemura M; Morishita Y
Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators in clinical practice: a safety overview.
Ellis AJ; Hendrick VM; Williams R; Komm BS
Expert Opin Drug Saf; 2015 Jun; 14(6):921-34. PubMed ID: 25936229
[TBL] [Abstract][Full Text] [Related]
19. A naturally occurring estrogen receptor mutation results in increased estrogenicity of a tamoxifen analog.
Catherino WH; Wolf DM; Jordan VC
Mol Endocrinol; 1995 Aug; 9(8):1053-63. PubMed ID: 7476979
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Antiestrogen-Promoted Pro-Survival Autophagy and Tamoxifen Resistance in Breast Cancer through Vitamin D Receptor.
Li Y; Cook KL; Yu W; Jin L; Bouker KB; Clarke R; Hilakivi-Clarke L
Nutrients; 2021 May; 13(5):. PubMed ID: 34069442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
